Afficher la couverture 'MicroRNAs and other small silencing RNAs in cancer. | Rovira, Carlos' en grand format
/5

0 avis

MicroRNAs and other small silencing RNAs in cancer.

Archive ouverte

Rovira, Carlos | Güida, Maria C | Cayota, Alfonso

Edité par CCSD ; Wiley -

International audience. Small noncoding RNAs are key controllers of cellular function, and their deregulation can lead to cancer development and metastatic evolution. This review summarizes the most important examples of small RNAs involved in human cancer and discusses their clinical use as biomarkers and drug targets for diagnosis, prognosis, and treatment of cancer. We also describe the possible mechanisms underlying small RNA-mediated transformation and outline the future describing new small RNA families with great potential in cancer biology.

Consulter en ligne

Suggestions

Du même auteur

Cloning, characterization and subcellular localization of a Trypanosoma cruzi argonaute protein defining a new subfamily distinctive of trypanosomatids.

Archive ouverte | Garcia Silva, Maria R | CCSD

International audience. Over the last years an expanding family of small non-coding RNAs (sRNA) has been identified in eukaryotic genomes which behave as sequence-specific triggers for mRNA degradation, translation ...

A population of tRNA-derived small RNAs is actively produced in Trypanosoma cruzi and recruited to specific cytoplasmic granules.

Archive ouverte | Garcia-Silva, Maria Rosa | CCSD

International audience. Over the last years an expanding family of small RNAs (i.e. microRNAs, siRNAs and piRNAs) was recognized as key players in diverse forms of gene silencing and chromatin organization. Effector...

Fine-tuning the metabolic rewiring and adaptation of translational machinery during an epithelial-mesenchymal transition in breast cancer cells

Archive ouverte | Fernandez-Calero, Tamara | CCSD

International audience. Background - During breast cancer progression, the epithelial to mesenchymal transition has been associated with metastasis and endocrine therapy resistance; however, the underlying mechanism...

Chargement des enrichissements...